Free Trial
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free PLXS Stock Alerts

Plexus (PLXS) Financials

Plexus logo
$268.36 +0.47 (+0.18%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$268.44 +0.08 (+0.03%)
As of 05/29/2026 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Plexus

Annual Income Statements for Plexus

This table shows Plexus' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/3/2015 10/1/2016 9/30/2017 9/29/2018 9/28/2019 10/3/2020 10/2/2021 10/1/2022 9/30/2023 9/28/2024 9/27/2025
Net Income / (Loss) Attributable to Common Shareholders		 94 76 112 13 109 117 141 138 151 147 180
Consolidated Net Income / (Loss)		 94 76 112 13 109 117 139 138 139 112 173
Net Income / (Loss) Continuing Operations		 94 76 112 13 109 117 139 138 139 112 173
Total Pre-Tax Income 		106 87 122 108 126 135 160 158 161 130 188
Total Operating Income		 115 99 130 118 142 153 176 178 196 168 202
Total Gross Profit		 240 227 256 258 292 313 323 347 395 379 407
Total Revenue		 2,654 2,556 2,528 2,874 3,164 3,390 3,369 3,811 4,210 3,961 4,033
Operating Revenue		 2,654 2,556 2,528 2,874 3,164 3,390 3,369 3,811 4,210 3,961 4,033
Total Cost of Revenue		 2,415 2,329 2,272 2,616 2,873 3,078 3,046 3,464 3,816 3,582 3,626
Operating Cost of Revenue		 2,415 2,329 2,272 2,616 2,873 3,078 3,046 3,464 3,816 3,582 3,626
Total Operating Expenses		 124 128 126 139 150 159 147 169 199 211 204
Selling, General & Admin Expense		 122 121 126 139 148 153 144 167 176 191 199
Restructuring Charge		 1.70 7.03 0.00 0.00 1.68 6.00 3.27 2.02 23 20 4.68
Total Other Income / (Expense), net		 -9.14 -12 -8.09 -11 -16 -18 -16 -20 -35 -38 -14
Interest Expense		 14 15 14 12 13 16 14 16 32 29 12
Interest & Investment Income		 3.50 4.24 5.04 4.70 1.95 1.88 1.37 1.31 3.14 3.86 3.92
Other Income / (Expense), net		 1.32 -1.65 0.45 -3.14 -5.20 -3.69 -2.98 -5.33 -6.40 -13 -6.67
Income Tax Expense		 12 11 9.76 95 17 18 21 20 22 18 15
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - - - -5.32 - -22 -54 -16
Basic Earnings per Share		 $2.81 $2.29 $3.33 $0.40 $3.59 $4.02 $4.86 $4.96 $5.04 $4.08 $6.39
Weighted Average Basic Shares Outstanding		 33.62M 33.37M 33.61M 33.00M 30.27M 29.20M 28.58M 27.86M 27.58M 27.40M 27.04M
Diluted Earnings per Share		 $2.74 $2.24 $3.24 $0.38 $3.50 $3.93 $4.76 $4.86 $4.95 $4.01 $6.26
Weighted Average Diluted Shares Outstanding		 34.38M 34.10M 34.55M 33.92M 31.07M 29.92M 29.17M 28.44M 28.11M 27.91M 27.62M
Weighted Average Basic & Diluted Shares Outstanding		 33.60M 33.40M 33.70M 32.60M 29.18M 29.20M 28.00M 27.63M 27.47M 27.09M 26.77M

Quarterly Income Statements for Plexus

This table shows Plexus' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026
Net Income / (Loss) Attributable to Common Shareholders		 46 29 16 18 83 37 49 45 49 45 39
Consolidated Net Income / (Loss)		 40 29 16 25 41 37 39 45 51 41 50
Net Income / (Loss) Continuing Operations		 40 29 16 25 41 37 39 45 51 41 50
Total Pre-Tax Income 		46 35 19 30 45 43 45 50 50 51 58
Total Operating Income		 53 45 29 39 54 47 49 54 53 54 62
Total Gross Profit		 97 88 88 94 108 101 98 103 105 106 119
Total Revenue		 1,024 983 967 961 1,051 976 980 1,018 1,058 1,070 1,164
Operating Revenue		 1,024 983 967 961 1,051 976 980 1,018 1,058 1,070 1,164
Total Cost of Revenue		 927 894 879 866 943 875 882 915 954 964 1,045
Operating Cost of Revenue		 927 894 879 866 943 875 882 915 954 964 1,045
Total Operating Expenses		 43 43 59 55 54 54 49 50 52 52 57
Selling, General & Admin Expense		 43 43 48 46 54 49 49 50 52 52 57
Restructuring Charge		 - 0.00 11 9.22 - 4.68 0.00 0.00 - 0.00 0.00
Total Other Income / (Expense), net		 -6.94 -10 -11 -8.94 -8.44 -3.37 -3.77 -3.77 -3.45 -3.43 -3.96
Interest Expense		 8.13 7.62 8.29 7.39 5.58 3.55 3.14 2.50 2.41 2.89 3.42
Interest & Investment Income		 0.85 0.81 0.82 1.02 1.22 1.23 0.87 0.93 0.88 0.98 0.81
Other Income / (Expense), net		 0.35 -3.50 -3.03 -2.57 -4.09 -1.05 -1.50 -2.21 -1.92 -1.53 -1.35
Income Tax Expense		 6.14 5.63 2.73 5.16 4.19 6.23 5.95 4.72 -1.76 9.85 8.07
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - 8.67 - - -19 - - -4.76 14
Basic Earnings per Share		 $1.46 $1.06 $0.59 $0.92 $1.51 $1.38 $1.44 $1.67 $1.90 $1.54 $1.86
Weighted Average Basic Shares Outstanding		 27.58M 27.49M 27.54M 27.36M 27.40M 27.09M 27.11M 27.06M 27.04M 26.77M 26.76M
Diluted Earnings per Share		 $1.45 $1.04 $0.58 $0.91 $1.48 $1.34 $1.41 $1.64 $1.87 $1.51 $1.82
Weighted Average Diluted Shares Outstanding		 28.11M 28.01M 27.93M 27.77M 27.91M 27.76M 27.66M 27.53M 27.62M 27.35M 27.31M
Weighted Average Basic & Diluted Shares Outstanding		 27.47M 27.61M 27.39M 27.23M 27.09M 27.04M 27.09M 26.99M 26.77M 26.79M 26.76M

Annual Cash Flow Statements for Plexus

This table details how cash moves in and out of Plexus' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/3/2015 10/1/2016 9/30/2017 9/29/2018 9/28/2019 10/3/2020 10/2/2021 10/1/2022 9/30/2023 9/28/2024 9/27/2025
Net Change in Cash & Equivalents		 16 80 135 -273 -71 162 -117 4.96 -19 91 -41
Net Cash From Operating Activities		 77 128 172 67 115 210 143 -26 166 437 249
Net Cash From Continuing Operating Activities		 77 128 172 67 115 210 143 -26 166 437 249
Net Income / (Loss) Continuing Operations		 94 76 112 13 109 117 139 138 139 112 173
Consolidated Net Income / (Loss)		 94 76 112 13 109 117 139 138 139 112 173
Depreciation Expense		 48 47 45 48 52 57 61 63 70 78 78
Non-Cash Adjustments To Reconcile Net Income		 13 21 18 1.07 57 8.61 113 481 -1.72 -4.87 -140
Changes in Operating Assets and Liabilities, net		 -80 -17 -3.22 4.42 -102 28 -170 -708 -41 252 139
Net Cash From Investing Activities		 -35 -27 -38 -75 -89 -50 -57 -102 -93 -95 -96
Net Cash From Continuing Investing Activities		 -35 -27 -38 -75 -89 -50 -57 -102 -93 -95 -96
Purchase of Property, Plant & Equipment		 -35 -31 -39 -63 -91 -50 -57 -102 -104 -95 -95
Other Investing Activities, net		 - - 0.00 0.00 1.24 0.24 0.13 0.05 11 0.24 -0.35
Net Cash From Financing Activities		 -26 -21 1.31 -265 -97 -1.46 -204 139 -93 -256 -196
Net Cash From Continuing Financing Activities		 -26 -21 1.31 -265 -97 -1.46 -204 139 -93 -256 -196
Repayment of Debt		 -488 -630 -303 -971 -994 -639 -466 -558 -788 -739 -593
Repurchase of Common Equity		 -30 -30 -34 -137 -182 -41 -108 -50 -41 -56 -65
Issuance of Debt		 483 625 331 834 1,085 679 377 758 749 551 477
Other Financing Activities, net		 8.61 14 7.25 8.22 -5.42 -0.11 -6.11 -11 -12 -11 -15
Effect of Exchange Rate Changes		 - - - - - 2.58 0.90 -6.54 1.39 4.84 2.08
Cash Interest Paid		 13 15 14 12 16 15 14 15 33 30 12
Cash Income Taxes Paid		 11 11 10 19 26 31 40 17 44 46 45

Quarterly Cash Flow Statements for Plexus

This table details how cash moves in and out of Plexus' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026
Net Change in Cash & Equivalents		 3.10 -24 33 4.80 78 -30 -7.29 -73 69 -57 54
Net Cash From Operating Activities		 90 -3.03 88 132 220 54 37 27 132 -15 28
Net Cash From Continuing Operating Activities		 90 -3.03 88 132 220 54 37 27 132 -15 28
Net Income / (Loss) Continuing Operations		 40 29 16 25 41 37 39 45 51 41 50
Consolidated Net Income / (Loss)		 40 29 16 25 41 37 39 45 51 41 50
Depreciation Expense		 18 19 19 20 20 19 20 20 19 19 19
Non-Cash Adjustments To Reconcile Net Income		 -41 -36 8.35 14 24 -82 75 -120 -14 10 -14
Changes in Operating Assets and Liabilities, net		 72 -15 44 73 136 79 -97 82 75 -86 -26
Net Cash From Investing Activities		 -16 -29 -23 -18 -26 -26 -20 -14 -35 -35 -13
Net Cash From Continuing Investing Activities		 -16 -29 -23 -18 -26 -26 -20 -14 -35 -35 -13
Purchase of Property, Plant & Equipment		 -24 -29 -23 -17 -26 -27 -20 -14 -35 -35 -12
Other Investing Activities, net		 8.66 0.07 0.27 -0.21 0.11 0.05 -0.08 -0.38 0.07 0.06 -0.09
Net Cash From Financing Activities		 -70 5.76 -31 -109 -121 -53 -25 -90 -28 -7.99 38
Net Cash From Continuing Financing Activities		 -70 5.76 -31 -109 -121 -53 -25 -90 -28 -7.99 38
Repayment of Debt		 -242 -124 -202 -213 -200 -76 -89 -238 -190 -180 -110
Repurchase of Common Equity		 -3.52 0.00 -18 -19 -20 -13 -13 -18 -22 -22 -21
Issuance of Debt		 176 133 196 123 99 40 88 167 184 198 187
Other Financing Activities, net		 -0.17 -2.91 -7.91 -0.01 -0.12 -3.07 -11 -0.57 -0.15 -4.04 -17
Effect of Exchange Rate Changes		 -0.83 1.62 -1.13 -0.57 - -4.01 - - 0.00 1.17 0.08

Annual Balance Sheets for Plexus

This table presents Plexus' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/3/2015 10/1/2016 9/30/2017 9/29/2018 9/28/2019 10/3/2020 10/2/2021 10/1/2022 9/30/2023 9/28/2024 9/27/2025
Total Assets		 1,692 1,766 1,976 1,933 2,001 2,290 2,462 3,393 3,321 3,154 3,137
Total Current Assets		 1,334 1,433 1,617 1,517 1,538 1,779 1,931 2,816 2,672 2,477 2,399
Cash & Equivalents		 357 433 569 297 224 386 270 275 256 345 306
Restricted Cash		 - 0.00 0.39 0.42 2.49 2.09 0.34 0.67 0.42 2.35 0.29
Accounts Receivable		 385 417 366 395 488 482 520 738 662 622 657
Inventories, net		 569 564 655 794 701 763 972 1,603 1,562 1,311 1,230
Prepaid Expenses		 23 19 28 30 32 32 53 62 50 75 55
Other Current Assets		 - - - 0.00 91 114 115 139 142 121 151
Plant, Property, & Equipment, net		 317 291 315 341 384 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 40 41 44 74 78 511 531 577 649 677 738
Noncurrent Deferred & Refundable Income Taxes		 4.66 4.83 5.29 11 14 21 27 39 63 74 91
Other Noncurrent Operating Assets		 36 36 39 63 65 489 504 538 586 603 647
Total Liabilities & Shareholders' Equity		 1,692 1,766 1,976 1,933 2,001 2,290 2,462 3,393 3,321 3,154 3,137
Total Liabilities		 849 849 950 1,011 1,135 1,312 1,434 2,297 2,107 1,829 1,683
Total Current Liabilities		 579 650 908 738 866 1,004 1,129 2,006 1,813 1,643 1,519
Short-Term Debt		 3.51 79 287 5.53 101 147 66 274 240 157 46
Accounts Payable		 401 397 414 506 445 516 635 806 647 606 727
Accrued Expenses		 - 48 49 68 106 103 147 58 71 76 61
Current Employee Benefit Liabilities		 49 42 49 67 74 77 75 89 94 94 109
Other Current Liabilities		 44 - - - - - - 779 760 - 576
Total Noncurrent Liabilities		 270 199 43 274 270 309 305 291 294 186 164
Long-Term Debt		 258 184 26 183 - - 187 188 191 - 92
Noncurrent Deferred & Payable Income Tax Liabilities		 - - 0.00 14 5.31 6.43 5.68 6.33 4.35 8.23 6.00
Other Noncurrent Operating Liabilities		 12 15 16 20 18 61 64 55 68 70 66
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 842 917 1,026 921 866 977 1,028 1,096 1,214 1,325 1,455
Total Preferred & Common Equity		 842 917 1,026 921 866 977 1,028 1,096 1,214 1,325 1,455
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 842 917 1,026 921 866 977 1,028 1,096 1,214 1,325 1,455
Common Stock		 498 531 556 582 598 622 640 653 662 681 696
Retained Earnings		 861 937 1,049 1,062 1,179 1,295 1,434 1,572 1,711 1,823 1,996
Treasury Stock		 -510 - - - - - -1,043 -1,093 -1,134 -1,190 -1,255
Accumulated Other Comprehensive Income / (Loss)		 -6.47 -12 -4.98 -12 -18 -5.06 -2.98 -36 -24 11 18

Quarterly Balance Sheets for Plexus

This table presents Plexus' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 12/31/2022 4/1/2023 7/1/2023 12/30/2023 3/30/2024 6/29/2024 12/28/2024 3/29/2025 6/28/2025 1/3/2026 4/4/2026
Total Assets		 3,395 3,382 3,419 3,305 3,277 3,171 3,071 3,086 3,106 3,186 3,361
Total Current Assets		 2,814 2,780 2,799 2,650 2,631 2,541 2,387 2,396 2,395 2,457 2,637
Cash & Equivalents		 248 270 253 232 265 270 317 311 238 249 303
Restricted Cash		 0.03 0.70 0.59 0.43 0.04 0.02 0.69 0.03 0.05 0.60 0.05
Accounts Receivable		 734 661 707 656 646 644 597 609 664 680 702
Inventories, net		 1,645 1,650 1,642 1,575 1,519 1,434 1,290 1,280 1,278 1,305 1,374
Prepaid Expenses		 68 66 64 55 71 77 54 60 71 70 98
Other Current Assets		 119 133 133 132 131 116 128 136 145 153 160
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets		 581 602 620 654 646 630 684 689 711 729 724
Noncurrent Deferred & Refundable Income Taxes		 39 39 40 63 63 55 74 74 74 91 92
Other Noncurrent Operating Assets		 542 562 579 592 583 575 610 616 637 638 632
Total Liabilities & Shareholders' Equity		 3,395 3,382 3,419 3,305 3,277 3,171 3,071 3,086 3,106 3,186 3,361
Total Liabilities		 2,245 2,200 2,235 2,038 2,017 1,905 1,752 1,734 1,687 1,705 1,871
Total Current Liabilities		 1,954 1,918 1,941 1,744 1,737 1,725 1,565 1,566 1,516 1,544 1,712
Short-Term Debt		 329 294 305 251 246 258 122 121 51 67 143
Accounts Payable		 754 729 697 647 627 593 666 680 722 746 852
Accrued Expenses		 296 286 277 61 74 63 74 69 61 68 61
Current Deferred Revenue		 - - - - 716 - 625 612 593 580 565
Current Employee Benefit Liabilities		 64 77 80 75 73 75 78 84 90 82 91
Total Noncurrent Liabilities		 291 282 294 294 280 180 187 168 170 161 159
Capital Lease Obligations		 - - - - 192 - - 89 - 91 91
Noncurrent Deferred & Payable Income Tax Liabilities		 5.62 4.90 4.44 4.41 4.43 4.29 7.23 7.22 5.99 5.16 5.16
Other Noncurrent Operating Liabilities		 56 57 70 66 66 68 74 72 72 65 63
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,150 1,182 1,184 1,267 1,260 1,266 1,319 1,352 1,419 1,481 1,490
Total Preferred & Common Equity		 1,150 1,182 1,184 1,267 1,260 1,266 1,319 1,352 1,419 1,481 1,490
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 1,150 1,182 1,184 1,267 1,260 1,266 1,319 1,352 1,419 1,481 1,490
Common Stock		 655 652 656 664 664 671 685 681 689 700 690
Retained Earnings		 1,614 1,655 1,671 1,741 1,757 1,782 1,860 1,899 1,945 2,037 2,087
Treasury Stock		 -1,105 -1,117 - -1,134 -1,152 -1,171 - -1,215 -1,234 -1,278 -1,299
Accumulated Other Comprehensive Income / (Loss)		 -14 -7.74 -12 -3.44 -8.70 -16 -24 -14 20 22 11

Annual Metrics And Ratios for Plexus

This table displays calculated financial ratios and metrics derived from Plexus' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 10/3/2015 10/1/2016 9/30/2017 9/29/2018 9/28/2019 10/3/2020 10/2/2021 10/1/2022 9/30/2023 9/28/2024 9/27/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 11.61% -3.70% -1.09% 13.66% 10.12% 7.14% -0.64% 13.14% 10.47% -5.93% 1.82%
EBITDA Growth		 9.65% -12.23% 21.00% -6.97% 15.68% 9.15% 13.54% 0.53% 10.03% -10.33% 17.68%
EBIT Growth		 13.71% -16.25% 33.31% -11.67% 18.86% 9.37% 15.77% -0.25% 9.58% -18.41% 26.63%
NOPAT Growth		 8.96% -15.11% 37.42% -88.01% 754.65% 8.63% 14.70% 1.94% 8.71% -14.41% 28.52%
Net Income Growth		 8.16% -18.98% 46.63% -88.36% 732.94% 8.16% 18.24% -0.48% 0.62% -19.61% 54.62%
EPS Growth		 8.73% -18.25% 44.64% -88.27% 821.05% 12.29% 21.12% 2.10% 1.85% -18.99% 56.11%
Operating Cash Flow Growth		 -13.41% 66.82% 34.44% -61.08% 72.52% 82.45% -32.23% -118.40% 731.94% 163.24% -42.90%
Free Cash Flow Firm Growth		 376.38% 55.22% 9.66% -129.10% 126.02% 1,770.10% -51.49% -274.84% 154.09% 395.15% -59.48%
Invested Capital Growth		 6.56% -0.08% 3.14% 5.49% 14.19% -0.31% 9.38% 26.80% 8.33% -11.82% 4.98%
Revenue Q/Q Growth		 0.09% -0.61% 0.67% 3.66% 1.25% 3.13% -2.04% 0.00% 0.00% 0.68% 0.19%
EBITDA Q/Q Growth		 -1.45% -3.63% 5.23% 2.14% 0.97% 7.13% -2.60% 279.48% 0.00% -1.15% 0.41%
EBIT Q/Q Growth		 -1.85% -4.77% 7.26% 2.16% 0.69% 9.25% -3.89% 0.00% 0.00% -2.47% 0.73%
NOPAT Q/Q Growth		 -3.17% -5.24% 10.18% 142.19% -24.07% 0.25% -3.82% 0.00% 0.00% 1.95% 3.49%
Net Income Q/Q Growth		 -2.67% -5.88% 9.71% 142.49% -24.85% 0.75% -3.05% 0.00% 0.00% 0.87% 6.28%
EPS Q/Q Growth		 -2.84% -5.49% 9.46% 140.43% -21.35% 1.55% -2.26% 0.00% 0.00% 0.75% 6.64%
Operating Cash Flow Q/Q Growth		 -11.30% -11.05% 35.17% -26.79% 255.94% 4.77% -42.82% -77.50% 0.00% 42.55% -26.12%
Free Cash Flow Firm Q/Q Growth		 -4.61% -21.31% 41.40% -511.61% 108.53% 0.81% -62.81% 54.59% 130.00% 40.59% -37.67%
Invested Capital Q/Q Growth		 0.43% 3.05% 0.66% 10.43% -5.57% -5.65% 5.20% 5.51% -2.41% -8.97% -2.93%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 9.03% 8.90% 10.12% 8.96% 9.22% 9.22% 9.60% 9.11% 9.37% 9.56% 10.08%
EBITDA Margin		 6.23% 5.68% 6.95% 5.69% 5.97% 6.09% 6.96% 6.18% 6.16% 5.87% 6.78%
Operating Margin		 4.35% 3.89% 5.14% 4.12% 4.49% 4.52% 5.23% 4.68% 4.65% 4.23% 5.02%
EBIT Margin		 4.40% 3.83% 5.16% 4.01% 4.32% 4.41% 5.14% 4.54% 4.50% 3.90% 4.85%
Profit (Net Income) Margin		 3.55% 2.99% 4.43% 0.45% 3.43% 3.47% 4.12% 3.63% 3.30% 2.82% 4.29%
Tax Burden Percent		 88.75% 87.45% 91.99% 12.12% 86.23% 86.77% 86.60% 87.33% 86.39% 86.32% 91.95%
Interest Burden Percent		 91.04% 89.37% 93.45% 93.46% 92.03% 90.46% 92.57% 91.58% 85.00% 83.81% 96.07%
Effective Tax Rate		 11.25% 12.55% 8.01% 87.88% 13.77% 13.23% 13.40% 12.67% 13.61% 13.68% 8.05%
Return on Invested Capital (ROIC)		 14.15% 11.65% 15.76% 1.81% 14.09% 14.37% 15.77% 13.57% 12.67% 11.08% 14.83%
ROIC Less NNEP Spread (ROIC-NNEP)		 23.40% 19.57% 19.25% 2.52% 72.74% -346.82% 54.86% -6.96% -4.01% -77.73% 24.63%
Return on Net Nonoperating Assets (RNNOA)		 -2.53% -2.96% -4.23% -0.47% -1.93% -1.63% -1.92% -0.55% -0.63% -2.27% -2.39%
Return on Equity (ROE)		 11.62% 8.69% 11.54% 1.34% 12.16% 12.75% 13.85% 13.02% 12.04% 8.81% 12.44%
Cash Return on Invested Capital (CROIC)		 7.79% 11.73% 12.67% -3.53% 0.84% 14.69% 6.82% -10.06% 4.67% 23.64% 9.97%
Operating Return on Assets (OROA)		 7.07% 5.66% 6.97% 5.89% 6.96% 6.98% 7.29% 5.90% 5.64% 4.77% 6.22%
Return on Assets (ROA)		 5.72% 4.42% 5.99% 0.67% 5.52% 5.48% 5.85% 4.72% 4.14% 3.45% 5.50%
Return on Common Equity (ROCE)		 11.62% 8.69% 11.54% 1.34% 12.16% 12.75% 13.85% 13.02% 12.04% 8.81% 12.44%
Return on Equity Simple (ROE_SIMPLE)		 11.20% 8.34% 10.92% 1.42% 12.55% 12.02% 13.51% 12.62% 11.45% 8.44% 0.00%
Net Operating Profit after Tax (NOPAT)		 102 87 119 14 122 133 153 156 169 145 186
NOPAT Margin		 3.86% 3.40% 4.73% 0.50% 3.87% 3.93% 4.53% 4.08% 4.02% 3.66% 4.61%
Net Nonoperating Expense Percent (NNEP)		 -9.25% -7.93% -3.49% -0.71% -58.65% 361.19% -39.09% 20.53% 16.67% 88.81% -9.81%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - - 11.69%
Cost of Revenue to Revenue		 90.98% 91.10% 89.88% 91.04% 90.78% 90.78% 90.40% 90.89% 90.63% 90.44% 89.92%
SG&A Expenses to Revenue		 4.61% 4.73% 4.98% 4.85% 4.68% 4.52% 4.27% 4.38% 4.17% 4.81% 4.95%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 4.68% 5.00% 4.98% 4.85% 4.73% 4.70% 4.36% 4.44% 4.72% 5.32% 5.06%
Earnings before Interest and Taxes (EBIT)		 117 98 130 115 137 150 173 173 189 155 196
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 165 145 176 163 189 206 234 236 259 232 273
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.55 1.74 1.89 2.15 2.25 2.17 2.58 2.27 2.15 2.87 2.72
Price to Tangible Book Value (P/TBV)		 1.55 1.74 1.89 2.15 2.25 2.17 2.58 2.27 2.15 2.87 2.72
Price to Revenue (P/Rev)		 0.49 0.62 0.77 0.69 0.61 0.63 0.79 0.65 0.62 0.96 0.98
Price to Earnings (P/E)		 13.85 20.87 17.29 152.19 17.90 18.07 18.84 18.01 17.34 25.95 21.97
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 7.22% 4.79% 5.78% 0.66% 5.59% 5.53% 5.31% 5.55% 5.77% 3.85% 4.55%
Enterprise Value to Invested Capital (EV/IC)		 1.62 1.91 2.18 2.31 2.16 2.24 2.61 2.09 2.01 3.03 2.95
Enterprise Value to Revenue (EV/Rev)		 0.46 0.56 0.67 0.65 0.63 0.61 0.78 0.70 0.66 0.94 0.94
Enterprise Value to EBITDA (EV/EBITDA)		 7.32 9.81 9.57 11.48 10.61 10.03 11.26 11.36 10.76 15.95 13.85
Enterprise Value to EBIT (EV/EBIT)		 10.37 14.57 12.90 16.29 14.66 13.83 15.23 15.48 14.72 23.99 19.35
Enterprise Value to NOPAT (EV/NOPAT)		 11.82 16.38 14.07 130.85 16.37 15.55 17.29 17.20 16.48 25.61 20.35
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.82 11.15 9.79 28.06 17.40 9.84 18.51 0.00 16.82 8.49 15.20
Enterprise Value to Free Cash Flow (EV/FCFF)		 21.46 16.26 17.51 0.00 275.83 15.22 40.01 0.00 44.70 12.00 30.26
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.31 0.29 0.31 0.20 0.33 0.34 0.25 0.42 0.36 0.19 0.09
Long-Term Debt to Equity		 0.31 0.20 0.03 0.20 0.22 0.19 0.18 0.17 0.16 0.07 0.06
Financial Leverage		 -0.11 -0.15 -0.22 -0.19 -0.03 0.00 -0.04 0.08 0.16 0.03 -0.10
Leverage Ratio		 2.03 1.97 1.93 2.01 2.20 2.33 2.37 2.76 2.91 2.55 2.26
Compound Leverage Factor		 1.85 1.76 1.80 1.88 2.03 2.11 2.19 2.52 2.47 2.14 2.17
Debt to Total Capital		 23.71% 22.26% 23.38% 17.00% 24.96% 25.51% 19.77% 29.65% 26.20% 15.73% 8.65%
Short-Term Debt to Total Capital		 0.32% 6.66% 21.43% 0.50% 8.73% 11.19% 5.17% 17.59% 14.60% 10.01% 2.88%
Long-Term Debt to Total Capital		 23.39% 15.60% 1.95% 16.50% 16.23% 14.32% 14.59% 12.06% 11.60% 5.72% 5.78%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 76.29% 77.74% 76.62% 83.00% 75.04% 74.49% 80.23% 70.35% 73.80% 84.27% 91.35%
Debt to EBITDA		 1.58 1.81 1.78 1.15 1.52 1.62 1.08 1.96 1.66 1.06 0.50
Net Debt to EBITDA		 -0.58 -1.17 -1.46 -0.67 0.33 -0.26 -0.07 0.79 0.67 -0.43 -0.62
Long-Term Debt to EBITDA		 1.56 1.27 0.15 1.12 0.99 0.91 0.80 0.80 0.74 0.39 0.34
Debt to NOPAT		 2.56 3.02 2.62 13.16 2.35 2.52 1.66 2.97 2.55 1.71 0.74
Net Debt to NOPAT		 -0.93 -1.96 -2.14 -7.61 0.50 -0.40 -0.11 1.20 1.03 -0.69 -0.91
Long-Term Debt to NOPAT		 2.52 2.12 0.22 12.77 1.53 1.41 1.23 1.21 1.13 0.62 0.49
Altman Z-Score		 3.97 4.03 3.89 4.11 4.06 3.87 3.92 2.88 3.23 3.79 4.13
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.30 2.20 1.78 2.06 1.78 1.77 1.71 1.40 1.47 1.51 1.58
Quick Ratio		 1.28 1.31 1.03 0.94 0.82 0.86 0.70 0.50 0.51 0.59 0.63
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 56 88 96 -28 7.27 136 66 -115 62 309 125
Operating Cash Flow to CapEx		 220.87% 481.74% 453.91% 107.37% 127.26% 420.00% 249.70% -25.82% 159.37% 458.60% 261.62%
Free Cash Flow to Firm to Interest Expense		 4.04 5.99 7.07 -2.29 0.57 8.41 4.63 -7.27 1.98 10.70 10.78
Operating Cash Flow to Interest Expense		 5.48 8.73 12.65 5.47 8.97 13.02 10.00 -1.65 5.26 15.12 21.48
Operating Cash Flow Less CapEx to Interest Expense		 3.00 6.92 9.86 0.38 1.92 9.92 6.00 -8.06 1.96 11.82 13.27
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.61 1.48 1.35 1.47 1.61 1.58 1.42 1.30 1.25 1.22 1.28
Accounts Receivable Turnover		 7.49 6.38 6.46 7.56 7.17 6.99 6.73 6.06 6.02 6.17 6.31
Inventory Turnover		 4.41 4.11 3.73 3.61 3.84 4.20 3.51 2.69 2.41 2.49 2.85
Fixed Asset Turnover		 8.14 8.40 8.34 8.76 8.72 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 6.06 5.84 5.60 5.68 6.04 6.40 5.29 4.81 5.26 5.72 5.44
Days Sales Outstanding (DSO)		 48.73 57.23 56.48 48.29 50.93 52.23 54.27 60.21 60.65 59.16 57.87
Days Inventory Outstanding (DIO)		 82.78 88.83 97.89 101.09 95.00 86.84 104.01 135.66 151.37 146.39 127.89
Days Payable Outstanding (DPO)		 60.24 62.53 65.15 64.21 60.44 57.00 68.99 75.89 69.46 63.83 67.08
Cash Conversion Cycle (CCC)		 71.27 83.53 89.22 85.17 85.49 82.07 89.29 119.98 142.56 141.71 118.68
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 747 746 770 812 927 924 1,011 1,282 1,389 1,225 1,286
Invested Capital Turnover		 3.67 3.42 3.33 3.63 3.64 3.66 3.48 3.32 3.15 3.03 3.21
Increase / (Decrease) in Invested Capital		 46 -0.63 23 42 115 -2.91 87 271 107 -164 61
Enterprise Value (EV)		 1,211 1,425 1,682 1,876 2,006 2,069 2,639 2,676 2,788 3,708 3,788
Market Capitalization		 1,306 1,595 1,938 1,985 1,944 2,123 2,657 2,490 2,614 3,808 3,957
Book Value per Share		 $25.04 $27.42 $30.53 $28.58 $29.56 $33.42 $36.40 $39.54 $44.19 $48.66 $53.90
Tangible Book Value per Share		 $25.04 $27.42 $30.53 $28.58 $29.56 $33.42 $36.40 $39.54 $44.19 $48.66 $53.90
Total Capital		 1,104 1,179 1,339 1,110 1,154 1,312 1,282 1,557 1,645 1,572 1,592
Total Debt		 262 263 313 189 288 335 253 462 431 247 138
Total Long-Term Debt		 258 184 26 183 187 188 187 188 191 90 92
Net Debt		 -95 -170 -256 -109 62 -53 -17 186 174 -100 -169
Capital Expenditures (CapEx)		 35 27 38 62 91 50 57 102 104 95 95
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 401 428 428 487 547 535 598 808 843 644 619
Debt-free Net Working Capital (DFNWC)		 758 861 997 785 773 922 868 1,084 1,100 991 926
Net Working Capital (NWC)		 755 783 710 779 673 776 802 810 860 834 880
Net Nonoperating Expense (NNE)		 8.11 11 7.44 1.29 14 16 14 17 30 33 13
Net Nonoperating Obligations (NNO)		 -95 -170 -256 -109 62 -53 -17 186 174 -100 -169
Total Depreciation and Amortization (D&A)		 49 47 45 48 52 57 61 63 70 78 78
Debt-free, Cash-free Net Working Capital to Revenue		 15.11% 16.76% 16.91% 16.96% 17.29% 15.77% 17.75% 21.21% 20.02% 16.25% 15.35%
Debt-free Net Working Capital to Revenue		 28.57% 33.70% 39.43% 27.32% 24.44% 27.21% 25.78% 28.44% 26.12% 25.02% 22.96%
Net Working Capital to Revenue		 28.43% 30.63% 28.08% 27.13% 21.26% 22.88% 23.81% 21.25% 20.42% 21.05% 21.82%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.81 $2.29 $3.33 $0.40 $3.59 $4.02 $4.86 $4.96 $5.04 $4.08 $6.39
Adjusted Weighted Average Basic Shares Outstanding		 33.62M 33.37M 33.61M 33.00M 30.27M 29.20M 28.58M 27.86M 27.58M 27.40M 27.04M
Adjusted Diluted Earnings per Share		 $2.74 $2.24 $3.24 $0.38 $3.50 $3.93 $4.76 $4.86 $4.95 $4.01 $6.26
Adjusted Weighted Average Diluted Shares Outstanding		 34.38M 34.10M 34.55M 33.92M 31.07M 29.92M 29.17M 28.44M 28.11M 27.91M 27.62M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 33.42M 33.51M 33.59M 31.47M 29.18M 28.82M 28.00M 27.63M 27.47M 27.09M 26.77M
Normalized Net Operating Profit after Tax (NOPAT)		 104 93 119 83 124 138 155 157 189 162 190
Normalized NOPAT Margin		 3.92% 3.64% 4.73% 2.88% 3.92% 4.08% 4.62% 4.13% 4.49% 4.10% 4.72%
Pre Tax Income Margin		 4.00% 3.42% 4.82% 3.74% 3.98% 3.99% 4.76% 4.15% 3.82% 3.27% 4.66%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 8.36 6.68 9.60 9.42 10.65 9.26 12.16 10.90 6.01 5.35 16.86
NOPAT to Interest Expense		 7.34 5.94 8.80 1.17 9.53 8.23 10.71 9.81 5.36 5.01 16.03
EBIT Less CapEx to Interest Expense		 5.88 4.87 6.81 4.33 3.60 6.16 8.15 4.49 2.71 2.06 8.65
NOPAT Less CapEx to Interest Expense		 4.85 4.13 6.01 -3.92 2.48 5.13 6.70 3.40 2.06 1.72 7.83
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 31.80% 39.25% 30.46% 1,050.87% 167.66% 35.23% 78.07% 36.45% 29.44% 49.80% 37.79%

Quarterly Metrics And Ratios for Plexus

This table displays calculated financial ratios and metrics derived from Plexus' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 1/3/2026 4/4/2026
DEI Shares Outstanding		 - - - - - - - - - - 26,786,466.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 26,786,466.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 1.46
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -8.89% -10.18% -9.71% -5.96% 2.60% -0.66% 1.37% 5.99% 0.74% 9.60% 18.73%
EBITDA Growth		 -7.46% -15.19% -36.78% 125.56% -3.75% 7.28% 45.81% 25.83% 1.60% 10.66% 19.37%
EBIT Growth		 -13.46% -24.80% -52.21% 46.65% -7.28% 9.98% 78.83% 40.15% 2.86% 15.55% 27.91%
NOPAT Growth		 -16.19% -22.63% -48.14% 26.97% 5.63% 6.05% 67.82% 49.06% 12.50% 9.47% 25.68%
Net Income Growth		 -20.21% -30.75% -60.24% 59.12% 2.38% 27.56% 140.61% 79.46% 24.76% 10.51% 27.48%
EPS Growth		 -17.61% -30.20% -60.00% 62.50% 2.07% 28.85% 143.10% 80.22% 26.35% 12.69% 29.08%
Operating Cash Flow Growth		 23,017.60% 93.79% -17.13% 0.00% 145.03% 1,870.78% -58.21% -79.57% -40.03% -128.68% -22.43%
Free Cash Flow Firm Growth		 71.96% 96.61% 93.85% 160.47% 452.06% 1,554.52% 1,869.31% -36.94% -102.78% -143.73% -152.05%
Invested Capital Growth		 8.33% 4.15% 2.72% -5.46% -11.82% -17.98% -12.69% -1.56% 4.98% 14.66% 13.58%
Revenue Q/Q Growth		 0.23% -4.04% -1.60% -0.64% 9.35% -7.09% 0.41% 3.89% 3.93% 1.09% 8.78%
EBITDA Q/Q Growth		 188.17% -15.64% -24.64% 23.13% 22.97% -5.98% 2.43% 6.26% -0.72% 2.40% 10.49%
EBIT Q/Q Growth		 114.63% -22.40% -36.52% 38.71% 35.70% -7.95% 3.22% 8.70% -0.40% 3.40% 14.26%
NOPAT Q/Q Growth		 80.48% -18.19% -33.36% 29.04% 50.15% -17.87% 5.46% 14.61% 13.33% -20.09% 21.08%
Net Income Q/Q Growth		 154.83% -27.44% -44.42% 54.81% 63.97% -9.59% 4.85% 15.47% 13.99% -19.92% 20.95%
EPS Q/Q Growth		 158.93% -28.28% -44.23% 56.90% 62.64% -9.46% 5.22% 16.31% 14.02% -19.25% 20.53%
Operating Cash Flow Q/Q Growth		 0.00% -103.37% 2,998.51% 49.90% 67.27% -75.63% -31.59% -26.74% 391.08% -111.65% 285.04%
Free Cash Flow Firm Q/Q Growth		 66.82% 65.25% 39.75% 970.44% 93.18% 43.58% -26.71% -68.98% -108.53% -2,155.09% 12.77%
Invested Capital Q/Q Growth		 -2.41% 6.39% -3.04% -6.09% -8.97% -1.04% 3.22% 5.87% -2.93% 8.09% 2.24%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 9.45% 8.97% 9.11% 9.83% 10.27% 10.32% 9.97% 10.14% 9.90% 9.92% 10.24%
EBITDA Margin		 7.04% 6.19% 4.74% 5.87% 6.60% 6.68% 6.82% 6.97% 6.66% 6.75% 6.85%
Operating Margin		 5.21% 4.60% 3.05% 4.08% 5.13% 4.80% 4.98% 5.26% 5.02% 5.09% 5.31%
EBIT Margin		 5.24% 4.24% 2.73% 3.82% 4.74% 4.69% 4.82% 5.05% 4.84% 4.95% 5.20%
Profit (Net Income) Margin		 3.93% 2.97% 1.68% 2.62% 3.92% 3.82% 3.99% 4.43% 4.86% 3.85% 4.28%
Tax Burden Percent		 86.78% 83.84% 85.62% 82.96% 90.77% 85.68% 86.78% 90.53% 103.55% 80.70% 86.06%
Interest Burden Percent		 86.43% 83.65% 71.73% 82.62% 91.25% 94.94% 95.21% 96.95% 97.01% 96.40% 95.69%
Effective Tax Rate		 13.23% 16.16% 14.38% 17.04% 9.23% 14.32% 13.22% 9.47% -3.55% 19.30% 13.94%
Return on Invested Capital (ROIC)		 14.25% 10.91% 7.37% 9.63% 14.10% 12.10% 12.77% 14.37% 16.70% 13.03% 14.76%
ROIC Less NNEP Spread (ROIC-NNEP)		 10.91% 7.30% 2.71% 4.96% -6.54% 6.53% 3.70% 57.80% 19.35% 15.82% 18.77%
Return on Net Nonoperating Assets (RNNOA)		 1.70% 1.45% 0.43% 0.64% -0.19% 0.26% 0.10% -0.34% -1.87% -1.12% -1.12%
Return on Equity (ROE)		 15.95% 12.35% 7.80% 10.28% 13.91% 12.36% 12.88% 14.03% 14.82% 11.91% 13.63%
Cash Return on Invested Capital (CROIC)		 4.67% 6.86% 6.86% 15.87% 23.64% 30.68% 25.77% 15.04% 9.97% 0.93% 2.31%
Operating Return on Assets (OROA)		 6.57% 5.19% 3.28% 4.56% 5.80% 5.82% 6.02% 6.47% 6.20% 6.53% 6.95%
Return on Assets (ROA)		 4.93% 3.64% 2.02% 3.12% 4.80% 4.74% 4.97% 5.68% 6.23% 5.08% 5.72%
Return on Common Equity (ROCE)		 15.95% 12.35% 7.80% 10.28% 13.91% 12.36% 12.88% 14.03% 14.82% 11.91% 13.63%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 9.96% 8.06% 8.75% 0.00% 9.09% 10.56% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 46 38 25 33 49 40 42 49 55 44 53
NOPAT Margin		 4.52% 3.85% 2.61% 3.39% 4.65% 4.11% 4.32% 4.77% 5.20% 4.11% 4.57%
Net Nonoperating Expense Percent (NNEP)		 3.34% 3.61% 4.67% 4.67% 20.64% 5.56% 9.07% -43.43% -2.65% -2.79% -4.01%
Return On Investment Capital (ROIC_SIMPLE)		 - 2.21% - - - 2.62% 2.71% 3.11% 3.45% 2.68% 3.09%
Cost of Revenue to Revenue		 90.55% 91.03% 90.89% 90.17% 89.73% 89.68% 90.03% 89.86% 90.10% 90.08% 89.76%
SG&A Expenses to Revenue		 4.24% 4.37% 4.92% 4.78% 5.15% 5.04% 5.00% 4.88% 4.88% 4.83% 4.93%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 4.24% 4.37% 6.06% 5.74% 5.15% 5.51% 5.00% 4.88% 4.88% 4.83% 4.93%
Earnings before Interest and Taxes (EBIT)		 54 42 26 37 50 46 47 51 51 53 60
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 72 61 46 56 69 65 67 71 70 72 80
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.15 2.39 2.10 2.26 2.87 3.32 2.61 2.63 2.72 2.81 3.80
Price to Tangible Book Value (P/TBV)		 2.15 2.39 2.10 2.26 2.87 3.32 2.61 2.63 2.72 2.81 3.80
Price to Revenue (P/Rev)		 0.62 0.74 0.66 0.73 0.96 1.11 0.89 0.93 0.98 1.01 1.31
Price to Earnings (P/E)		 17.34 21.98 24.72 26.18 25.95 28.30 18.86 17.40 21.97 22.15 31.75
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 5.77% 4.55% 4.05% 3.82% 3.85% 3.53% 5.30% 5.75% 4.55% 4.51% 3.15%
Enterprise Value to Invested Capital (EV/IC)		 2.01 2.19 1.97 2.19 3.03 3.53 2.74 2.75 2.95 2.93 3.94
Enterprise Value to Revenue (EV/Rev)		 0.66 0.79 0.71 0.75 0.94 1.08 0.87 0.90 0.94 0.99 1.30
Enterprise Value to EBITDA (EV/EBITDA)		 10.76 13.05 19.22 12.52 15.95 18.05 13.32 13.35 13.85 14.52 19.07
Enterprise Value to EBIT (EV/EBIT)		 14.72 18.44 19.22 18.58 23.99 26.93 19.12 18.72 19.35 20.08 25.89
Enterprise Value to NOPAT (EV/NOPAT)		 16.48 20.48 20.93 20.73 25.61 29.08 20.93 20.23 20.35 21.45 27.87
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.82 15.31 0.00 9.61 8.49 8.67 7.77 10.78 15.20 22.59 32.53
Enterprise Value to Free Cash Flow (EV/FCFF)		 44.70 32.63 29.11 13.40 12.00 10.36 9.93 18.11 30.26 335.27 181.57
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.36 0.35 0.35 0.28 0.19 0.16 0.16 0.10 0.09 0.11 0.16
Long-Term Debt to Equity		 0.16 0.15 0.15 0.07 0.07 0.07 0.07 0.07 0.06 0.06 0.06
Financial Leverage		 0.16 0.20 0.16 0.13 0.03 0.04 0.03 -0.01 -0.10 -0.07 -0.06
Leverage Ratio		 2.91 2.77 2.73 2.69 2.55 2.47 2.44 2.34 2.26 2.23 2.27
Compound Leverage Factor		 2.51 2.32 1.96 2.22 2.33 2.34 2.32 2.27 2.20 2.15 2.17
Debt to Total Capital		 26.20% 25.92% 25.80% 21.60% 15.73% 13.77% 13.43% 9.15% 8.65% 9.64% 13.58%
Short-Term Debt to Total Capital		 14.60% 14.69% 14.49% 15.98% 10.01% 7.97% 7.75% 3.24% 2.88% 4.08% 8.30%
Long-Term Debt to Total Capital		 11.60% 11.24% 11.31% 5.62% 5.72% 5.80% 5.68% 5.90% 5.78% 5.56% 5.28%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 73.80% 74.08% 74.20% 78.40% 84.27% 86.23% 86.57% 90.85% 91.35% 90.36% 86.42%
Debt to EBITDA		 1.66 1.79 2.98 1.48 1.06 0.89 0.81 0.52 0.50 0.56 0.80
Net Debt to EBITDA		 0.67 0.85 1.18 0.34 -0.43 -0.45 -0.39 -0.35 -0.62 -0.33 -0.24
Long-Term Debt to EBITDA		 0.74 0.77 1.31 0.39 0.39 0.37 0.34 0.34 0.34 0.33 0.31
Debt to NOPAT		 2.55 2.80 3.25 2.46 1.71 1.43 1.28 0.79 0.74 0.83 1.17
Net Debt to NOPAT		 1.03 1.33 1.28 0.56 -0.69 -0.73 -0.61 -0.53 -0.91 -0.48 -0.34
Long-Term Debt to NOPAT		 1.13 1.21 1.42 0.64 0.62 0.60 0.54 0.51 0.49 0.48 0.45
Altman Z-Score		 3.10 3.24 3.11 3.28 3.68 4.01 3.74 3.89 3.98 4.05 4.36
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.47 1.52 1.51 1.47 1.51 1.53 1.53 1.58 1.58 1.59 1.54
Quick Ratio		 0.51 0.51 0.52 0.53 0.59 0.58 0.59 0.59 0.63 0.60 0.59
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -60 -21 -13 110 213 306 224 70 -5.93 -134 -117
Operating Cash Flow to CapEx		 370.39% -10.57% 384.06% 758.17% 836.75% 202.19% 181.67% 196.01% 379.11% -43.70% 228.51%
Free Cash Flow to Firm to Interest Expense		 -7.44 -2.76 -1.53 14.92 38.19 86.05 71.44 27.80 -2.46 -46.31 -34.09
Operating Cash Flow to Interest Expense		 11.05 -0.40 10.59 17.81 39.47 15.09 11.70 10.75 54.71 -5.33 8.32
Operating Cash Flow Less CapEx to Interest Expense		 8.07 -4.16 7.83 15.46 34.75 7.63 5.26 5.27 40.28 -17.51 4.68
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.25 1.22 1.20 1.19 1.22 1.24 1.25 1.28 1.28 1.32 1.34
Accounts Receivable Turnover		 6.02 5.90 6.11 5.83 6.17 6.31 6.32 6.16 6.31 6.46 6.57
Inventory Turnover		 2.41 2.31 2.29 2.32 2.49 2.49 2.55 2.67 2.85 2.86 2.92
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 5.26 5.31 5.35 5.53 5.72 5.43 5.46 5.50 5.44 5.26 5.06
Days Sales Outstanding (DSO)		 60.65 61.89 59.70 62.66 59.16 57.86 57.73 59.27 57.87 56.48 55.54
Days Inventory Outstanding (DIO)		 151.37 158.08 159.36 157.38 146.39 146.75 143.22 136.92 127.89 127.51 124.94
Days Payable Outstanding (DPO)		 69.46 68.79 68.23 65.99 63.83 67.27 66.90 66.37 67.08 69.36 72.12
Cash Conversion Cycle (CCC)		 142.56 151.19 150.83 154.05 141.71 137.34 134.05 129.82 118.68 114.64 108.37
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,389 1,478 1,433 1,345 1,225 1,212 1,251 1,324 1,286 1,390 1,421
Invested Capital Turnover		 3.15 2.83 2.83 2.84 3.03 2.94 2.96 3.02 3.21 3.17 3.23
Increase / (Decrease) in Invested Capital		 107 59 38 -78 -164 -266 -182 -21 61 178 170
Enterprise Value (EV)		 2,788 3,240 2,821 2,944 3,708 4,274 3,433 3,637 3,788 4,072 5,594
Market Capitalization		 2,614 3,029 2,648 2,865 3,808 4,381 3,534 3,731 3,957 4,163 5,663
Book Value per Share		 $44.19 $46.12 $45.74 $46.28 $48.66 $48.69 $49.99 $52.38 $53.90 $55.32 $55.62
Tangible Book Value per Share		 $44.19 $46.12 $45.74 $46.28 $48.66 $48.69 $49.99 $52.38 $53.90 $55.32 $55.62
Total Capital		 1,645 1,710 1,698 1,615 1,572 1,530 1,561 1,562 1,592 1,639 1,724
Total Debt		 431 443 438 349 247 211 210 143 138 158 234
Total Long-Term Debt		 191 192 192 91 90 89 89 92 92 91 91
Net Debt		 174 211 173 79 -100 -107 -101 -95 -169 -91 -69
Capital Expenditures (CapEx)		 24 29 23 17 26 27 20 14 35 35 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 843 925 875 804 644 626 641 692 619 730 765
Debt-free Net Working Capital (DFNWC)		 1,100 1,158 1,140 1,074 991 944 951 929 926 980 1,068
Net Working Capital (NWC)		 860 907 894 816 834 822 830 879 880 913 925
Net Nonoperating Expense (NNE)		 6.02 8.64 8.99 7.42 7.66 2.88 3.27 3.41 3.57 2.77 3.41
Net Nonoperating Obligations (NNO)		 174 211 173 79 -100 -107 -101 -95 -169 -91 -69
Total Depreciation and Amortization (D&A)		 18 19 19 20 20 19 20 20 19 19 19
Debt-free, Cash-free Net Working Capital to Revenue		 20.02% 22.58% 21.90% 20.45% 16.25% 15.83% 16.15% 17.18% 15.35% 17.70% 17.74%
Debt-free Net Working Capital to Revenue		 26.12% 28.25% 28.54% 27.31% 25.02% 23.87% 23.98% 23.09% 22.96% 23.74% 24.78%
Net Working Capital to Revenue		 20.42% 22.12% 22.38% 20.74% 21.05% 20.79% 20.93% 21.83% 21.82% 22.12% 21.46%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.46 $1.06 $0.59 $0.92 $1.51 $1.38 $1.44 $1.67 $1.90 $1.54 $1.86
Adjusted Weighted Average Basic Shares Outstanding		 27.58M 27.49M 27.54M 27.36M 27.40M 27.09M 27.11M 27.06M 27.04M 26.77M 26.76M
Adjusted Diluted Earnings per Share		 $1.45 $1.04 $0.58 $0.91 $1.48 $1.34 $1.41 $1.64 $1.87 $1.51 $1.82
Adjusted Weighted Average Diluted Shares Outstanding		 28.11M 28.01M 27.93M 27.77M 27.91M 27.76M 27.66M 27.53M 27.62M 27.35M 27.31M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 27.47M 27.61M 27.39M 27.23M 27.09M 27.04M 27.09M 26.99M 26.77M 26.79M 26.76M
Normalized Net Operating Profit after Tax (NOPAT)		 46 38 35 40 49 44 42 49 37 44 53
Normalized NOPAT Margin		 4.52% 3.85% 3.59% 4.18% 4.65% 4.52% 4.32% 4.77% 3.51% 4.11% 4.57%
Pre Tax Income Margin		 4.53% 3.55% 1.96% 3.15% 4.32% 4.46% 4.59% 4.89% 4.69% 4.77% 4.97%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 6.60 5.47 3.19 4.96 8.92 12.89 15.07 20.55 21.22 18.33 17.68
NOPAT to Interest Expense		 5.69 4.97 3.04 4.41 8.77 11.30 13.50 19.40 22.79 15.22 15.55
EBIT Less CapEx to Interest Expense		 3.62 1.71 0.43 2.61 4.21 5.43 8.64 15.07 6.78 6.14 14.04
NOPAT Less CapEx to Interest Expense		 2.71 1.21 0.29 2.06 4.05 3.83 7.06 13.92 8.36 3.03 11.91
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 29.44% 23.37% 0.00% 35.78% 49.80% 57.16% 44.49% 38.94% 37.79% 42.37% 44.47%

Financials Breakdown Chart

Key Financial Trends

Plexus (PLXS) has shown solid profitability and a healthy balance sheet across the last four years of quarterly results. Here are the most relevant themes for investors based on the latest four years of cash flow, income statement, and balance sheet data.

  • Net income from continuing operations has remained positive in the most recent four quarters, with a peak of $51.4M in Q4 2025 and $41.18M in Q1 2026, underscoring ongoing profitability.
  • Strong liquidity profile, with cash & equivalents typically in the $240M–$320M range. Most recently, Q1 2026 cash & equivalents were about $248.8M, supporting balance-sheet resilience.
  • Operating cash flow has been a meaningful positive contributor in multiple quarters (examples: Q4 2024 $132.0M; Q2–Q4 2025 in the mid-to-high tens of millions), indicating the ability to generate cash from core operations.
  • Net cash position is generally favorable, with cash exceeding near-term debt in recent periods, contributing to a net cash balance of roughly $90M as of Q1 2026 (cash around $248.8M vs. total debt roughly $159M).
  • Revenue runs near the $1B-per-quarter level with modest fluctuations over the four-year window, suggesting steady scale but no clear, sustained multi-year growth trend yet.
  • Gross margin has typically been in the single-digits to low-teens (roughly 9–10%), indicating a relatively tight margin structure and potential sensitivity to cost changes or mix.
  • Capital expenditure (PPE) remains moderate and recurring (examples around $14–$35M per quarter), implying ongoing investment without excessive impairment of free cash flow.
  • Debt levels are modest and stable (long-term debt generally around $90–92M, short-term debt varying but manageable); the balance sheet shows a balanced lever with ample liquidity.
  • Q1 2026 shows negative cash flow from operations, with net cash from continuing operating activities around -$15.38M and a total net change in cash of -$57.34M for the quarter, signaling a temporary cash outflow that may reflect working capital timing or one-off factors.
05/31/26 08:49 PM ETAI Generated. May Contain Errors.

Plexus Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Plexus' financial year ends in September. Their financial year 2025 ended on September 27, 2025.

Plexus' net income appears to be on an upward trend, with a most recent value of $172.89 million in 2025, rising from $94.33 million in 2015. The previous period was $111.82 million in 2024. Find out what analysts predict for Plexus in the coming months.

Plexus' total operating income in 2025 was $202.37 million, based on the following breakdown:
  • Total Gross Profit: $406.51 million
  • Total Operating Expenses: $204.14 million

Over the last 10 years, Plexus' total revenue changed from $2.65 billion in 2015 to $4.03 billion in 2025, a change of 51.9%.

Plexus' total liabilities were at $1.68 billion at the end of 2025, a 8.0% decrease from 2024, and a 98.1% increase since 2015.

In the past 10 years, Plexus' cash and equivalents has ranged from $223.76 million in 2019 to $568.86 million in 2017, and is currently $306.46 million as of their latest financial filing in 2025.

Over the last 10 years, Plexus' book value per share changed from 25.04 in 2015 to 53.90 in 2025, a change of 115.3%.


Related Companies

Financial statements for NASDAQ:PLXS last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel